ESTIMATING SCENARIOS FOR SURVIVAL TIME IN PATIENTS WITH METASTATIC MELANOMA STARTING TARGETED THERAPIES AND IMMUNOTHERAPY

被引:0
|
作者
Vasista, A. [1 ,2 ]
Stockler, M. R. [1 ]
Carlino, M. S. [2 ,3 ]
Kiely, B. E. [1 ]
机构
[1] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[2] Univ Sydney, Westmead Hosp, Sydney, NSW, Australia
[3] Melanoma Inst Australia, Sydney, NSW, Australia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:70 / 70
页数:1
相关论文
共 50 条
  • [1] ESTIMATING SCENARIOS FOR SURVIVAL TIME IN PATIENTS WITH METASTATIC MELANOMA RECEIVING IMMUNOTHERAPY OR TARGETED THERAPY
    Smith-Uffen, Megan
    Park, John
    Parsonson, Andrew
    Vasista, Anuradha
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A452 - A452
  • [2] Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy
    Smith-Uffen, Megan
    Park, John
    Parsonson, Andrew
    Vasista, Anuradha
    [J]. CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)
  • [3] Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy
    Smith-Uffen, M.
    Park, J.
    Parsonson, A.
    Vasista, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S1611 - S1611
  • [4] Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapy
    Smith-Uffen, Megan
    Park, John
    Parsonson, Andrew
    Kiely, Belinda E.
    Vasista, Anuradha
    [J]. ONCOLOGIST, 2024,
  • [5] Estimating scenarios for survival time in patients with HER2 positive, metastatic breast cancer starting HER2 targeted therapies
    Vasista, A.
    Stockler, M.
    West, T.
    Wilcken, N.
    Kiely, B.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S216 - S216
  • [6] ESTIMATING SCENARIOS FOR SURVIVAL TIME IN PATIENTS WITH HER2 POSITIVE, METASTATIC BREAST CANCER (MBC) STARTING HER2 TARGETED THERAPIES
    Vasista, A.
    Stockler, M.
    West, T.
    Wilcken, N.
    Kiely, B.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 44 - 45
  • [7] Combining Immunotherapy and Targeted Therapies With Cryotherapy in Patients With Cutaneous Metastatic Melanoma
    Akay, Bengu Nisa
    Aydemir, Ahmet Taha
    [J]. DERMATOLOGIC SURGERY, 2024, 50 (08) : 770 - 772
  • [8] Toxicities with targeted therapies after immunotherapy in metastatic melanoma
    Grogan, Nicole
    Swami, Umang
    Bossler, Aaron D.
    Zakharia, Yousef
    Milhem, Mohammed
    [J]. MELANOMA RESEARCH, 2018, 28 (06) : 600 - 604
  • [9] Targeted Therapies for Metastatic Melanoma
    Chandra, Sunandana
    Pavlick, Anna C.
    [J]. DERMATOLOGIC CLINICS, 2012, 30 (03) : 517 - +
  • [10] Targeted therapies in metastatic Melanoma
    Hauschild, A.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 38 - 39